UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anti‐PF4 testing for vaccine‐induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021

Journal of thrombosis and haemostasis, 2021-09, Vol.19 (9), p.2263-2267

2021

Volltextzugriff (PDF)

Effects of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays using different reagents: Results of a UK NEQAS proficiency testing exercise

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-11, Vol.26 (6), p.1087-1091

2020

Volltextzugriff (PDF)

Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study

The Annals of pharmacotherapy, 2012-12, Vol.46 (12), p.1627-1636

2012

Volltextzugriff (PDF)

The effect of dabigatran on select specialty coagulation assays

American journal of clinical pathology, 2013-01, Vol.139 (1), p.102-109

2013

Volltextzugriff (PDF)

Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories

Clinical chemistry and laboratory medicine, 2008-01, Vol.46 (6), p.764-772

2008

Volltextzugriff (PDF)

A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one‐stage clotting and chromogenic substrate assays at clinical haemostasis laboratories

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-01, Vol.30 (1), p.214-223

2024

Volltextzugriff (PDF)

Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A

Haematologica (Roma), 2013-12, Vol.98 (12), p.1980-1987

2013

Volltextzugriff (PDF)

Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)

Clinical and applied thrombosis/hemostasis, 2021-12, Vol.27, p.10760296211066945-10760296211066945

2021

Volltextzugriff (PDF)

Quality in Laboratory Hemostasis and Thrombosis

1, 2009

Volltextzugriff (PDF)

Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1

Nutrients, 2020-04, Vol.12 (4), p.1148

2020

Volltextzugriff (PDF)

Improving access to hemophilia care in sub-Saharan Africa by capacity building

Blood advances, 2019-12, Vol.3 (Suppl 1), p.1-4

2019

Volltextzugriff (PDF)

Quality in Laboratory Hemostasis and Thrombosis

Second edition., 2013

Volltextzugriff (PDF)

Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro

Thrombosis and haemostasis, 2008-08, Vol.100 (2), p.350-355

2008

Volltextzugriff (PDF)

Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement Therapies

Seminars in thrombosis and hemostasis, 2017-04, Vol.43 (3), p.331-337

2017

Volltextzugriff (PDF)

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology

British journal of haematology, 2012-11, Vol.159 (4), p.427-429

2012

Volltextzugriff (PDF)

The natural history of glycogen storage disease type Ib in England: A multisite survey

JIMD reports, 2021-05, Vol.59 (1), p.52-59

2021

Volltextzugriff (PDF)

Development of national consensus statements on food labelling interpretation and protein allocation in a low phenylalanine diet for PKU

Orphanet journal of rare diseases, 2019-01, Vol.14 (1), p.2-2, Article 2

2019

Volltextzugriff (PDF)

The effect of a next generation factor VIII mimetic bispecific antibody (Mim8) on assays of factor VIII activity and thrombin generation

Journal of thrombosis and haemostasis, 2023-03, Vol.21 (3), p.480-487

2023

Volltextzugriff (PDF)

Effects of emicizumab on APTT, one‐stage and chromogenic assays of factor VIII in artificially spiked plasma and in samples from haemophilia A patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-05, Vol.26 (3), p.536-542

2020

Volltextzugriff (PDF)

Measurement of non‐Coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology

British journal of haematology, 2014-09, Vol.166 (6), p.830-841

2014

Volltextzugriff (PDF)

Both one-stage and chromogenic factor VIII assays are required for the diagnosis of mild hemophilia A

Journal of thrombosis and haemostasis, 2023-04, Vol.21 (4), p.773-775

2023

Volltextzugriff (PDF)

Laboratory D-dimer measurement: improved agreement between methods through calibration

Thrombosis and haemostasis, 2007-11, Vol.98 (5), p.1127-1135

2007

Volltextzugriff (PDF)

Frozen/Thawed Samples Can Replace Fresh Samples for Assignment of ISI to Secondary Thromboplastin Standards for Multiple Reagent/Instrument Combinations: Data to Support Possible Revision of WHO Guidelines

International journal of laboratory hematology, 2024-09

2024

Volltextzugriff (PDF)

Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice

Seminars in thrombosis and hemostasis, 2024-05, Vol.50 (8), p.1153

2024

Volltextzugriff (PDF)

A next generation FVIII mimetic bispecific antibody, Mim8, the impact on non‐factor VIII related haemostasis assays

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-11, Vol.29 (6), p.1633-1637

2023

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Englisch
(218)

Erscheinungsjahr

n.n

Thema

Science & Technology
(120)
Life Sciences & Biomedicine
(118)
Hematology
(93)
Humans
(89)
Haematology
(32)
Cardiovascular System & Cardiology
(30)
Peripheral Vascular Disease
(30)
Quality Control
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(27)
Clinical & Internal Medicine
(21)
Blood Coagulation Tests - Methods
(19)
Hemophilia
(19)
Laboratories
(19)
Coagulation Factors
(18)
Hematologic And Hematopoietic Diseases
(17)
Blood Coagulation
(15)
Coagulation
(15)
Reproducibility Of Results
(15)
Female
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Anti‐PF4 testing for vaccine‐induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021

Effects of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays using different reagents: Results of a UK NEQAS proficiency testing exercise

Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study

The effect of dabigatran on select specialty coagulation assays

Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories

A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one‐stage clotting and chromogenic substrate assays at clinical haemostasis laboratories

Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A

Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)

Quality in Laboratory Hemostasis and Thrombosis

Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1

Improving access to hemophilia care in sub-Saharan Africa by capacity building

Quality in Laboratory Hemostasis and Thrombosis

Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro

Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement Therapies

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology

The natural history of glycogen storage disease type Ib in England: A multisite survey

Development of national consensus statements on food labelling interpretation and protein allocation in a low phenylalanine diet for PKU

The effect of a next generation factor VIII mimetic bispecific antibody (Mim8) on assays of factor VIII activity and thrombin generation

Effects of emicizumab on APTT, one‐stage and chromogenic assays of factor VIII in artificially spiked plasma and in samples from haemophilia A patients with inhibitors

Measurement of non‐Coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology

Both one-stage and chromogenic factor VIII assays are required for the diagnosis of mild hemophilia A

Laboratory D-dimer measurement: improved agreement between methods through calibration

Frozen/Thawed Samples Can Replace Fresh Samples for Assignment of ISI to Secondary Thromboplastin Standards for Multiple Reagent/Instrument Combinations: Data to Support Possible Revision of WHO Guidelines

Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice

A next generation FVIII mimetic bispecific antibody, Mim8, the impact on non‐factor VIII related haemostasis assays

Suchergebnisse filtern